-
YAP-TEAD Regulation of Super-Enhancers in Surface Ectoderm F
2026-06-11
This study reveals how the YAP-TEAD transcriptional complex orchestrates the establishment and function of super-enhancers, driving early surface ectoderm lineage commitment. By integrating 3D genomics and CRISPR-based perturbation, the research clarifies mechanisms underlying epithelial differentiation and highlights new directions for regenerative medicine.
-
Foretinib (GSK1363089): Protocols and Pitfalls in Cancer Mod
2026-06-10
Foretinib (GSK1363089) enables precise, multikinase inhibition for dissecting tumor cell growth, motility, and metastasis in advanced cancer research. This guide delivers actionable protocols, troubleshooting insights, and data-driven workflow enhancements, empowering researchers with rigor and reproducibility.
-
CircRHOBTB3 Restricts Prostate Cancer via NONO-MAOA Regulati
2026-06-10
This study uncovers the tumor-suppressive function of circRHOBTB3 in prostate cancer, demonstrating that it impedes proliferation and metastasis by sequestering NONO and downregulating MAOA. The findings highlight circRHOBTB3 as a promising biomarker and therapeutic target for advanced PCa.
-
TBXA2R-ERM Axis: Driving Metastasis in Triple-Negative Breas
2026-06-09
The reference study uncovers a novel mechanism by which the thromboxane A2 receptor (TBXA2R), a GPCR, activates the ERM protein family to drive motility, invasion, and metastatic colonization in triple-negative breast cancer (TNBC) cells. This mechanistic insight into TBXA2R–ERM signaling reveals new targets for intervention in metastatic cancer progression.
-
Advancing In Vitro Drug Response Assessment in Cancer Resear
2026-06-09
Schwartz's dissertation introduces improved in vitro methodologies to distinguish growth inhibition from cell death in cancer drug evaluation. This nuanced approach enhances mechanistic understanding of anti-cancer agents and guides more precise experimental design for translational research.
-
LDN-193189: Advanced Insights for BMP Pathway Modulation
2026-06-08
Explore LDN-193189 as a potent ALK inhibitor for cutting-edge BMP pathway research. This article offers a unique, practical perspective on assay design, mechanistic details, and translational applications, setting it apart from existing reviews.
-
DAF-2 Diacetate: Precision Live-Cell Nitric Oxide Imaging Wo
2026-06-08
DAF-2 diacetate enables highly sensitive, real-time tracking of nitric oxide in live tissues, making it indispensable for studying dynamic NO signaling in complex systems like legume nodules. New research on sulfur-regulated nodule senescence unlocks advanced assay potential and troubleshooting strategies for optimizing NO detection with this robust fluorescent probe.
-
Syringin Natural Product: Protocols for Advanced RCC Researc
2026-06-07
Syringin, a high-purity natural product from APExBIO, enables researchers to dissect EGFR/PI3K/Akt signaling and overcome sunitinib resistance in renal cell carcinoma models. This guide details stepwise protocols, troubleshooting strategies, and key insights to maximize reproducibility and discovery in bioactive compound screening.
-
Cabozantinib (XL184): Advanced Workflows in RCC Signaling Re
2026-06-06
Cabozantinib (XL184) enables precision modeling of acute and chronic kinase pathway adaptation in renal cell carcinoma, supporting both phosphoproteomic and antiangiogenic studies. This guide delivers actionable workflows, troubleshooting insights, and key innovations for maximizing experimental rigor with this multi-kinase inhibitor.
-
One-step TUNEL Cy5 Apoptosis Detection Kit: Optimized Workfl
2026-06-05
The One-step TUNEL Cy5 Apoptosis Detection Kit streamlines high-sensitivity apoptosis detection in both tissue sections and cultured cells, leveraging robust Cy5 fluorescence. Its rapid one-step protocol and compatibility across diverse sample types empower researchers to efficiently quantify DNA fragmentation and interrogate cell death mechanisms, especially in oncology and drug resistance studies.
-
EPI-001: Advanced Mechanistic Insights for AR N-Terminal Dom
2026-06-05
Explore the advanced mechanism of EPI-001, a leading androgen receptor N-terminal domain inhibitor, and its impact on AR-driven prostate and triple-negative breast cancer research. This article offers a deep dive into molecular pathways, practical assay decisions, and critical distinctions from current protocols.
-
Maraviroc (UK-427857): Advanced HIV-1 & Neuroinflammation Wo
2026-06-04
Maraviroc (UK-427857) from APExBIO empowers high-precision HIV-1 entry inhibition and neuroinflammation studies with robust, reproducible protocols. Discover stepwise experimental enhancements, cross-domain applications, and troubleshooting tips that maximize assay reliability and data quality.
-
Saracatinib (AZD0530): Precision Src/Abl Inhibition in Cance
2026-06-04
Explore how Saracatinib (AZD0530) enables targeted inhibition of Src family and Abl kinases in cancer and neurobiology. Distinct from prior guides, this article analyzes translational assay design and the pivotal role of SFKs in both tumor and synaptic signaling.
-
Exosomal miR-17-5p–Bcl11b Axis Regulates Macrophage Polariza
2026-06-03
This study uncovers a novel regulatory axis in sepsis-induced lung injury, showing that reduced plasma exosomal miR-17-5p promotes pro-inflammatory macrophage polarization by targeting Bcl11b. These findings suggest new diagnostic and therapeutic directions for managing acute lung injury in sepsis.
-
Cyclic di-GMP: Transforming Biofilm and Immune Research Para
2026-06-03
Cyclic di-GMP is redefining our understanding of bacterial biofilm persistence and innate immune modulation. This article delivers mechanistic insights, protocol parameters, and strategic guidance for translational researchers leveraging high-purity cyclic di-GMP from APExBIO, linking primary research with workflow optimization in infection biology and cancer immunotherapy.
451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page